GeneDx Holdings Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
17 Sep 24 | SellUS$12,054,002 | OPKO Health, Inc. | Company | 330,472 | US$38.29 | |
23 Aug 24 | SellUS$5,007,094 | OPKO Health, Inc. | Company | 144,826 | US$35.38 | |
19 Aug 24 | SellUS$4,756,875 | OPKO Health, Inc. | Company | 139,824 | US$34.49 | |
13 Aug 24 | SellUS$2,898,314 | OPKO Health, Inc. | Company | 84,774 | US$34.76 | |
08 Aug 24 | SellUS$3,563,807 | OPKO Health, Inc. | Company | 112,994 | US$31.82 | |
31 Jul 24 | SellUS$2,976,346 | OPKO Health, Inc. | Company | 88,839 | US$33.50 | |
29 Jul 24 | SellUS$1,692,890 | OPKO Health, Inc. | Company | 50,000 | US$33.86 | |
26 Jul 24 | SellUS$4,560,363 | OPKO Health, Inc. | Company | 135,000 | US$33.85 | |
23 Jul 24 | SellUS$4,946,935 | OPKO Health, Inc. | Company | 150,000 | US$33.46 | |
17 Jul 24 | SellUS$823,188 | OPKO Health, Inc. | Company | 25,000 | US$32.93 | |
05 Jul 24 | SellUS$1,020,016 | OPKO Health, Inc. | Company | 36,118 | US$28.24 | |
03 Jul 24 | SellUS$2,457,286 | OPKO Health, Inc. | Company | 89,082 | US$29.12 | |
04 Jun 24 | BuyUS$2,757,117 | Casdin Capital, LLC | Company | 130,000 | US$22.52 | |
29 May 24 | BuyUS$842,604 | Casdin Capital, LLC | Company | 40,000 | US$21.07 | |
28 May 24 | BuyUS$3,424,989 | Casdin Capital, LLC | Company | 170,000 | US$20.61 | |
13 May 24 | BuyUS$1,165,295 | Casdin Capital, LLC | Company | 50,000 | US$23.31 | |
12 Mar 24 | SellUS$8,261 | Kareem Saad | Individual | 897 | US$9.21 | |
12 Mar 24 | SellUS$24,111 | Katherine Stueland | Individual | 2,618 | US$9.21 | |
12 Mar 24 | SellUS$8,574 | Kevin Feeley | Individual | 931 | US$9.21 | |
05 Mar 24 | BuyUS$357,652 | Casdin Capital, LLC | Company | 40,900 | US$8.83 | |
03 Jan 24 | SellUS$271 | Kareem Saad | Individual | 105 | US$2.58 | |
17 Nov 23 | BuyUS$161,368 | Jason Ryan | Individual | 114,742 | US$1.54 | |
15 Nov 23 | SellUS$1,140,027 | Corvex Management LP | Company | 883,742 | US$1.29 | |
08 Nov 23 | BuyUS$14,889 | Richard Pfenniger | Individual | 10,000 | US$1.49 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 333,144 | 1.24% |
Individual Insiders | 615,890 | 2.29% |
Public Companies | 2,171,674 | 8.06% |
Hedge Funds | 2,473,781 | 9.18% |
VC/PE Firms | 3,526,411 | 13.1% |
General Public | 3,632,868 | 13.5% |
Institutions | 14,182,129 | 52.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 4.5%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
3,732,633 | US$209.0m | 0% | 95.69% | |||
3,526,411 | US$197.5m | 0% | 13.69% | |||
2,473,781 | US$138.5m | 0% | 5.24% | |||
2,171,674 | US$121.6m | -39% | no data | |||
1,105,768 | US$61.9m | -1.85% | 47.05% | |||
1,051,874 | US$58.9m | -6.51% | 0.03% | |||
924,569 | US$51.8m | 274% | no data | |||
835,062 | US$46.8m | 0% | 0.22% | |||
788,201 | US$44.1m | 11.4% | no data | |||
573,039 | US$32.1m | 3.01% | 6.7% | |||
433,635 | US$24.3m | 0% | 0.17% | |||
391,486 | US$21.9m | 39,100,000% | 0.01% | |||
366,296 | US$20.5m | 0% | 0.04% | |||
347,252 | US$19.4m | 78.6% | no data | |||
333,144 | US$18.7m | 0% | no data | |||
311,401 | US$17.4m | 194% | 0.01% | |||
266,179 | US$14.9m | 285% | no data | |||
255,059 | US$14.3m | 20.7% | 9.86% | |||
237,541 | US$13.3m | -70.1% | no data | |||
233,446 | US$13.1m | 242% | 0.03% | |||
225,170 | US$12.6m | 0% | 2.06% | |||
202,063 | US$11.3m | 0% | 0.05% | |||
194,264 | US$10.9m | 0% | no data | |||
188,356 | US$10.5m | 0% | no data | |||
167,469 | US$9.4m | 0% | 5.12% |